Literature for inhibitor I04.979: pigment epithelium derived factor

(Topics flags: S Structure, A Assay, M Mutation, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. Abooshahab,R., Al-Salami,H. and Dass,C.R.
   Synergy between PEDF and Doxorubicin in Breast Cancer Cells: Effects on Metastatic and Metabolic Pathways
   Int J Mol Sci25, PubMed  Europe PubMed DOI
2023
2. Singh,N., Hansdah,K., Bouzid,A., Ray,C.S., Desai,A., Panda,K.C., Choudhury,J.C., Tekari,A., Masmoudi,S. and Ramchander,P.V.
   Genetic variants and altered expression of SERPINF1 confer disease susceptibility in patients with otosclerosis
   J Hum Genet68, 635-642. PubMed  Europe PubMed DOI
2022
3. Qu,Q., Park,K., Zhou,K., Wassel,D., Farjo,R., Criswell,T., Ma,J.X. and Zhang,Y.
   Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy
   Front Cell Dev Biol10, 1049678-1049678. PubMed  Europe PubMed DOI
4. Shahbazi,B., Arab,S.S., Mafakher,L., Azadmansh,K. and Teimoori-Toolabi,L.
   Computational assessment of pigment epithelium-derived factor as an anti-cancer protein during its interaction with the receptors
   J Biomol Struct Dyn1-17. PubMed  Europe PubMed DOI
2021
5. Abooshahab,R., Al-Salami,H. and Dass,C.R.
   The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target
   Biochem Pharmacol193, 114787-114787. PubMed  Europe PubMed DOI  V
6. Akiba,J., Yoshida,T., Sadashima,E., Murata,K., Matsui,T., Yamagishi,S.I., Kusano,H., Mihara,Y., Mizuochi,S., Kinjou,Y., Naito,Y., Hisaka,T., Sakai,H., Okuda,K., Nakashima,O. and Yano,H.
   The Expression of PEDF and its Putative Receptors in Hepatocellular Carcinoma and Background Liver Tissue
   Anticancer Res41, 1203-1212. PubMed  Europe PubMed DOI
7. Bagdadi,N., Sawaied,A., AbuMadighem,A., Lunenfeld,E. and Huleihel,M.
   The Expression Levels and Cellular Localization of Pigment Epithelium Derived Factor (PEDF) in Mouse Testis: Its Possible Involvement in the Differentiation of Spermatogonial Cells
   Int J Mol Sci22, PubMed  Europe PubMed DOI
2019
8. Yamagishi,S.I., Koga,Y., Sotokawauchi,A., Hashizume,N., Fukahori,S., Matsui,T. and Yagi,M.
   Therapeutic potential of pigment epithelium-derived factor in cancer
   Curr Pharm Des25, 313-324. PubMed  Europe PubMed DOI
2018
9. Harries,R.L., Owen,S., Ruge,F., Morgan,M., Li,J., Zhang,Z., Harding,K.G., Torkington,J., Jiang,W.G. and Cai,J.
   Impact of pigment epithelium-derived factor on colorectal cancer in vitro and in vivo
   Oncotarget9, 19192-19202. PubMed  Europe PubMed DOI
10. Jin,Z., Burrage,L.C., Jiang,M.M., Lee,Y.C., Bertin,T., Chen,Y., Tran,A., Gibbs,R.A., Jhangiani,S., Sutton,V.R., Rauch,F., Lee,B. and Jain,M.
    Whole-exome sequencing identifies an intronic cryptic splice site in SERPINF1 causing osteogenesis imperfecta Type VI
    JBMR Plus2, 235-239. PubMed  Europe PubMed DOI  M
11. Yamagishi,S.I. and Matsui,T.
    Pigment epithelium-derived factor: a novel therapeutic target for cardiometabolic diseases and related complications
    Curr Med Chem25, 1480-1500. PubMed  Europe PubMed DOI
2017
12. He,X., Cheng,R., Park,K., Benyajati,S., Moiseyev,G., Sun,C., Olson,L.E., Yang,Y., Eby,B.K., Lau,K. and Ma,J.-X.
    Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway
    Kidney Int91, 642-657. PubMed  Europe PubMed DOI
13. Wang,J.Y., Liu,Y., Song,L.J., Lv,F., Xu,X.J., San,A., Wang,J., Yang,H.M., Yang,Z.Y., Jiang,Y., Wang,O., Xia,W.B., Xing,X.P. and Li,M.
    Novel mutations in SERPINF1 result in rare osteogenesis imperfecta type VI
    Calcif Tissue Int100, 55-66. PubMed  Europe PubMed DOI  M
2016
14. Belkacemi,L. and Zhang,S.X.
    Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review
    J Exp Clin Cancer Res35, 4-4. PubMed  Europe PubMed DOI
15. Ziff,J.L., Crompton,M., Powell,H.R., Lavy,J.A., Aldren,C.P., Steel,K.P., Saeed,S.R. and Dawson,S.J.
    Mutations and altered expression of SERPINF1 in patients with familial otosclerosis
    Hum Mol Genet25, 2393-2403. PubMed  Europe PubMed DOI  M
2013
16. Alcantara,M.B. and Dass,C.R.
    Regulation of MT1-MMP and MMP-2 by the serpin PEDF: a promising new target for metastatic cancer
    Cell Physiol Biochem31, 487-494. PubMed  Europe PubMed DOI
2012
17. Bohm,A., Ordelheide,A.M., Machann,J., Heni,M., Ketterer,C., Machicao,F., Schick,F., Stefan,N., Fritsche,A., Haring,H.U. and Staiger,H.
    Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels
    PLoS ONE7, e34035-e34035. PubMed  Europe PubMed DOI  M
2011
18. Cai,J., Wu,L., Qi,X., Li Calzi,S., Caballero,S., Shaw,L., Ruan,Q., Grant,M.B. and Boulton,M.E.
    PEDF regulates vascular permeability by a gamma-secretase-mediated pathway
    PLoS ONE6, e21164-e21164. PubMed  Europe PubMed DOI
19. Homan,E.P., Rauch,F., Grafe,I., Lietman,C., Doll,J.A., Dawson,B., Bertin,T., Napierala,D., Morello,R., Gibbs,R., White,L., Miki,R., Cohn,D.H., Crawford,S., Travers,R., Glorieux,F.H. and Lee,B.
    Mutations in SERPINF1 cause osteogenesis imperfecta type VI
    J Bone Miner Res26, 2798-2803. PubMed  Europe PubMed DOI  M
20. Park,K., Lee,K., Zhang,B., Zhou,T., He,X., Gao,G., Murray,A.R. and Ma,J.X.
    Identification of a novel inhibitor of the canonical Wnt pathway
    Mol Cell Biol31, 3038-3051. PubMed  Europe PubMed DOI
21. Subramanian,P., Crawford,S.E. and Becerra,S.P.
    Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor
    Methods Enzymol499, 183-204. PubMed  Europe PubMed DOI  A
2010
22. Kawaguchi,T., Yamagishi,S.I. and Sata,M.
    Structure-function relationships of PEDF
    Curr Mol Med10, 302-311. PubMed  Europe PubMed DOI
23. Yabe,T., Sanagi,T. and Yamada,H.
    The neuroprotective role of PEDF: implication for the therapy of neurological disorders
    Curr Mol Med10, 259-266. PubMed  Europe PubMed DOI
24. Yamagishi,S.I., Matsui,T., Kawaguchi,T. and Sata,M.
    Pathophysiological role of pigment epithelium-derived factor (PEDF) in hepatic disorders
    Curr Med Chem17, 1995-2000. PubMed  Europe PubMed DOI
2009
25. Crowe,S., Wu,L.E., Economou,C., Turpin,S.M., Matzaris,M., Hoehn,K.L., Hevener,A.L., James,D.E., Duh,E.J. and Watt,M.J.
    Pigment epithelium-derived factor contributes to insulin resistance in obesity
    Cell Metab10, 40-47. PubMed  Europe PubMed DOI
26. Filleur,S., Nelius,T., de Riese,W. and Kennedy,R.C.
    Characterization of PEDF: a multi-functional serpin family protein
    J Cell Biochem106, 769-775. PubMed  Europe PubMed DOI  V
2006
27. Xu,X., Zhang,S.S., Barnstable,C.J. and Tombran-Tink,J.
    Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates
    BMC Genomics7, 248-248. PubMed  Europe PubMed DOI
2005
28. [YEAR:1-9-2005]Tombran-Tink,J.
    The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling
    Front Biosci10, 2131-2149. PubMed  Europe PubMed
2001
29. Simonovic,M., Gettins,P.G. and Volz,K.
    Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor
    Proc Natl Acad Sci U S A98, 11131-11135. PubMed  Europe PubMed DOI  S
1999
30. [YEAR:9-7-1999]Dawson,D.W., Volpert,O.V., Gillis,P., Crawford,S.E., Xu,H., Benedict,W. and Bouck,N.P.
    Pigment epithelium-derived factor: a potent inhibitor of angiogenesis
    Science285, 245-248. PubMed  Europe PubMed DOI